| Q34112190 | Association of serum vascular endothelial growth factor-C and lymphatic vessel density with lymph node metastasis and prognosis of patients with gastric cancer |
| Q93067565 | Association study between the polymorphisms of angiogenesis-related genes and cervical cancer susceptibility in Chinese Uygur population |
| Q24651871 | COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer |
| Q42759907 | Changes and prognostic value of serum vascular endothelial growth factor in patients with differentiated thyroid cancer |
| Q37156639 | Circulating lymphangiogenic growth factors in gastrointestinal solid tumors, could they be of any clinical significance? |
| Q36238149 | Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma |
| Q53456893 | Correlation between serum levels of vascular endothelial growth factor-C and sentinel lymph node status in early breast cancer. |
| Q36465664 | Decreased serum level and increased urinary excretion of vascular endothelial growth factor-C in patients with chronic kidney disease |
| Q34113726 | Distinct characteristics of circulating vascular endothelial growth factor-a and C levels in human subjects |
| Q36612618 | First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours |
| Q84190566 | Lymphangiogenesis and cancer metastasis |
| Q26797490 | Lymphangiogenic Markers and Their Impact on Nodal Metastasis and Survival in Non-Small Cell Lung Cancer--A Structured Review with Meta-Analysis |
| Q64950683 | Prediction Model for Nodal Disease Among Patients With Non-Small Cell Lung Cancer. |
| Q82978925 | Preoperative serum levels of serum VEGF-C is associated with distant metastasis in colorectal cancer patients |
| Q84542848 | Preoperative serum oxidative stress marker as a strong indicator of nodal involvement in clinical stage I lung adenocarcinoma |
| Q44776136 | Serum VEGF and VEGF-C values before surgery and after postoperative treatment in gastric cancer. |
| Q53279748 | Serum vascular endothelial growth factor (VEGF) and VEGF-C levels as tumor markers in patients with cervical carcinoma. |
| Q81260628 | Serum vascular endothelial growth factor levels in patients with non-small cell lung cancer |
| Q80232285 | Serum vascular endothelial growth factor-C and vascular endothelial growth factor level in patients with colorectal carcinoma and clinical significance |
| Q57788704 | Serum vascular endothelial growth factor-C levels predict lymph node metastasis and prognosis of patients with gallbladder cancer |
| Q42959444 | Serum vascular endothelial growth factor-C levels: A possible diagnostic marker for lymph node metastasis in patients with primary non-small cell lung cancer |
| Q35987896 | Serum vascular endothelial growth factors C and D as forecast tools for patients with gallbladder carcinoma |
| Q84701414 | Serum vascular endothelial growth factors a, C and d in human breast tumors |
| Q36611550 | The balance of VEGF-C and VEGFR-3 mRNA is a predictor of lymph node metastasis in non-small cell lung cancer |
| Q36901201 | VEGF-c expression in an in vivo model of orthotopic endometrial cancer and retroperitoneal lymph node metastasis |
| Q36957500 | Vascular endothelial growth factor C complements the ability of positron emission tomography to predict nodal disease in lung cancer |
| Q30981990 | Vascular endothelial growth factor C promotes cervical cancer metastasis via up-regulation and activation of RhoA/ROCK-2/moesin cascade. |